RE:"Altercyte or Overcyte" EDTXF, the "PINK Planter" ......Where art thou share price target? Where art thou the "Toronto Stock Exchange"
Our most recent comment from our most respected CMO, global leader ( aka global KOL ) was that recent recruitment in the TIGERIS phase 3b confirmatory trial was "BRISK" ...
I just wonder why Vicenza on it's glorious 40th birthday would choose the following presentation from a known top .00028 percentile global giant to be their "lead off hitter"?
I think I know, but I believe I've known for a looong time...
Clearly not back to when our stock traded at $41 / share up in Toronto..but dang close ; - )
Bon appetito..I can't wait to hear the science behind the BIG upcoming presentation at Vicenza!
Three exciting sessions on PMX sponsored by Spectral and our EU partner Estor ( see their web site @ estor.it )..scroll to the bottom of main page for detail of summary below.
My personal favorite will be the meaty middle section where our wrold recognized CMO speaks on Endotoxemia and by due course.."Endtoxemic Septic Shock" in a special presentation named ....
"Endotoxemia and Endotoxic Shock : why should we care"
Looking forward to the presentation next Tuesday, and looking forward to seeing the use of PMX ramped up in North America as the global usage pushes hard against the 350,000 patient #
Sceince ...like poise...counts! IMHO
PS --- let's get the Paradigm analyst onboard and explain to them the T.EDT listing and the importance of having a share price target whilst we "cover a company"